Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Senti Biosciences Q2 EPS $(2.45) Up From $(4.22) YoY

Author: Benzinga Newsdesk | August 13, 2024 04:57pm

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(2.45) per share. This is a 41.67 percent increase over losses of $(4.22) per share from the same period last year.

Posted In: SNTI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist